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Neuronal development requires a complex choreog-
raphy of transcriptional decisions to obtain specific
cellular identities. Realizing the ultimate goal of
identifying genome-wide signatures that define and
drive specific neuronal fates has been hampered by
enormous complexity in both time and space during
development. Here, we have paired high-throughput
purification of pyramidal neuron subclasses with
deep profiling of spatiotemporal transcriptional dy-
namics during corticogenesis to resolve lineage
choice decisions. We identified numerous features
ranging from spatial and temporal usage of alterna-
tive mRNA isoforms and promoters to a host of
mRNA genes modulated during fate specification.
Notably, we uncovered numerous long noncoding
RNAs with restricted temporal and cell-type-specific
expression. To facilitate future exploration, we pro-
vide an interactive online database to enable multi-
dimensional data mining and dissemination. This
multifaceted study generates a powerful resource
and informs understanding of the transcriptional
regulation underlying pyramidal neuron diversity in
the neocortex.
INTRODUCTION
The myriad and complexity of neuronal networks present in
the mammalian brain provide the basis for critical faculties,
such as sensory perception, motor behavior, and cognition.
The neocortex in particular plays a critical role in computing
higher-order brain functions, which are executed by an extreme
diversity of cortical neuronal classes. Decoding the origin of
this variety of neurons and defining the rules that shape andmaintain neuronal diversity in the neocortex, and in the CNS
more broadly, hold great potential but are still unmet goals.
Addressing this challenge requires both a high-throughput
neuronal subclass purification method and an integrative
approach that considers dynamic, multilayered transcriptional
regulation during the acquisition of distinct neuronal identities.
Similarly, combinatorial profiling of multiple neuronal subtypes
obtained from the same tissue may be required to understand
cross-regulatory events that shape circuits.
A variety of genetic and surgical approaches have been used
to attempt to resolve neocortical complexity and characterize
distinct neuronal cell types (Arlotta et al., 2005; Ayoub et al.,
2011; Belgard et al., 2011; Doyle et al., 2008; Fertuzinhos
et al., 2014; Fishell and Heintz, 2013; Guez-Barber et al., 2011;
Heiman et al., 2008; Lobo et al., 2006; Molyneaux et al., 2009;
Sugino et al., 2006). However, it remains challenging to mark
and purify defined neuronal subclasses, especially during devel-
opmental timelines, where the specificity of individual markers is
dynamic, and in a scalable manner that enables high-throughput
molecular profiling across many populations. We present here a
broadly applicable approach leveraging a combination of exper-
imental and systems-wide analyses to address this critical need.
Specifically, we have incorporated the knowledge gained from
other approaches to enable combinatorial immunodetection of
nuclearmarkers to resolve neocortical pyramidal neuron popula-
tions and their temporal changes during cortical development.
We sought to investigate the transcriptome of three different
subpopulations of cortical pyramidal neurons, selected for their
diversity of targets, their importance for cortical function, and
their direct clinical relevance. We profiled subcerebral projection
neurons (ScPN), which include the clinically significant cortico-
spinal motor neurons (CSMNs), callosal projection neurons
(CPNs), and corticothalamic projection neurons (CThPNs). To
characterize these subpopulations throughout development,
we used immunostaining against unique combinations of tran-
scription factors for fluorescence-activated cell sorting (FACS)
(Hrvatin et al., 2014). Using this approach, we identified molecu-
lar signatures that distinguish between populations. In fact, weNeuron 85, 275–288, January 21, 2015 ª2015 Elsevier Inc. 275
could discriminate among pyramidal neuron types at the height
of key decisions in fate specification, migration, and axon
targeting.
To comprehensively and systematically characterize the
molecular signatures underlying neuronal diversity, we per-
formed whole-transcriptome analyses by massively parallel
RNA sequencing. In total, we identified 8,864 genes with signif-
icant differential expression, 812 alternative promoter switches,
1,068 changes in protein-coding sequences, and 1,181 genes
that demonstrate significant shifts in their relative isoform abun-
dance during corticogenesis. Increasing evidence suggests that
long noncoding RNAs (lncRNAs) play essential roles in the spec-
ification and maintenance of cell identity (Dinger et al., 2008;
Grote et al., 2013; Guttman et al., 2011; Mercer and Mattick,
2013; Mercer et al., 2008; Ponting et al., 2009; Ramos et al.,
2013; Sauvageau et al., 2013). Accordingly, we assembled
5,195 lncRNAs from these data, 806 of which exhibit differential
expression across neuronal types over time.
Given the complexity and depth of this resource, we
have developed an intuitive web-based utility to facilitate
data dissemination (http://decon.fas.harvard.edu), exploration,
and future investigation, enabling researchers to navigate the
full extent of the dataset. Specifically, this utility allows re-
searchers to dynamically explore groups of genes meeting
user-defined expression criteria, examine upstream regulatory
mechanisms, identify expression data at the isoform level, and
examine processedRNA sequencing (RNA-seq) reads to identify
new exons and promoters for genes of interest. The data are in-
tegrated with other online resources, such as the Allen Brain
Atlas and the UCSC Genome Browser to facilitate cross-plat-
form discovery.
Collectively, this work provides an approach to purify multiple
classes of neurons from the same tissue without the need for
genetic labeling. The labeling and purification procedure is
compatible with high-throughput RNA sequencing, and it
enabled the generation of a deep resource of global transcrip-
tional controls over the developmental divergence of individual
classes of pyramidal neurons. The scalability of the methods
and independence from genetic labels makes this platform uni-
versally applicable to transcriptional and epigenetic profiling
and amenable to the screening of primary classes of neurons
from the human brain.
RESULTS
Scalable Purification of Molecularly Defined Neuronal
Populations
To investigate the transcriptional dynamics of neuronal fate de-
cisions, we chose to focus on pyramidal neurons of the
neocortex, a region of the brain with extraordinary neuronal di-
versity that remains underexplored at the molecular level. We
purified and profiled three classes of pyramidal neurons based
on the differential expression of a combination of three transcrip-
tion factors: BCL11B (CTIP2), TLE4, and SATB2 (Figure 1A).
Layer V subcerebral projection neurons, which include cortico-
spinal motor neurons, are identified by their high BCL11B, low
TLE4, and low SATB2 expression (Molyneaux et al., 2007). Cor-
ticothalamic projection neurons and subplate neurons (hereafter276 Neuron 85, 275–288, January 21, 2015 ª2015 Elsevier Inc.collectively referred to as CThPN) are identified by high TLE4
(Allen and Lobe, 1999), moderate BCL11B (Arlotta et al., 2005),
and low SATB2 expression. Interhemispheric callosal projection
neurons are identified by high SATB2, absent BCL11B, and ab-
sent TLE4 expression (Alcamo et al., 2008; Arlotta et al., 2005).
Cortical tissue was dissociated to a single cell suspension, and
cells were fixed with paraformaldehyde and concomitantly
permeabilized by saponin prior to immunocytochemistry with
chosen combinations of antibodies for FACS (Figures 1B–1F;
Experimental Procedures).
Despite changes inmarker gene expression at different stages
of development, we were able to use our labeling and FACS
strategy to reliably distinguish between the lineages of ScPN,
CPN, andCThPN as early as embryonic day 15.5 (E15.5) (Figures
1B–1E). For example, even though BCL11B functions as an ideal
discriminating marker later in development, BCL11B expression
at E15.5 is roughly equivalent between subcerebral projection
neurons and corticothalamic projection neurons, precluding
their distinction. However, differing levels of TLE4 can distin-
guish the two cell types at this stage. As a result, over time, we
can detect changes in levels of expression of each transcription
factor and therefore distinguish these three neuronal classes as
they diverge from each other during development (FACS plots;
Figures 1B–1E). We can also detect temporal changes in the
relative abundance of each cell type. For example, from E15.5
to postnatal day 1 (P1) CPN increase from 5.4% of total cells
to 26%, ScPN decrease from 6% to 1.1%, and CThPN remain
constant at approximately 6%.
To understand gene-regulatory changes in these populations,
we performed systematic and comprehensive whole-transcrip-
tome analyses. Briefly, we generated RNA-seq libraries with
two biological replicates for each neuronal type and across
several developmental stages (E15.5, E16.5, E18.5, and P1).
Despite fixation and reverse crosslinking, we obtained high-
quality total RNA from all purified cell populations with RNA
integrity numbers (RIN) ranging from 6.4 to 9 (median of 7.1).
Approximately 100,000 cells were required to obtain 200 ng of
total RNA, which served as input for the standard Illumina TruSeq
RNA-seq library preparation. Libraries were sequenced to a
mean of over 100 million mapped 100 base pair paired-end
reads per replicate (Table S1; Figures S1A–S1C, available on-
line). Merged assemblies were generated as described in Trap-
nell et al. (2012) and detailed in the Experimental Procedures
and used as input for our previously described long noncoding
RNA (lncRNA) identification pipeline (Cabili et al., 2011).
LncRNAs with a minimum of 33 coverage were appended to
the list of known UCSC protein-coding genes to establish a suit-
able reference transcriptome (Data S1) for isoform-level quanti-
fication and differential expression testingwith Cuffdiff2 (Trapnell
et al., 2013).
We first analyzed the sorted markers in our whole-transcrip-
tome analyses and found that they are in the expected popula-
tions. As anticipated, the expression profiles of Bcl11b, Satb2,
and Tle4 were consistent with known patterns of expression
in vivo (Figure 1G). This specificity extended more broadly to
a cohort of 150 genes known to have varying degrees of sub-
type-specific expression during development (Figure 1H and
Table S2) (Arlotta et al., 2005; Hoerder-Suabedissen andMolna´r,
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Figure 1. Scalable Purification of Molecularly
Defined Neuronal Populations
(A) Schematic overview of the purification of three distinct
neuronal subtypes for RNA-seq: callosal projection neu-
rons (CPN; green), subcerebral projection neurons (ScPN;
red), and corticothalamic/subplate neurons (CThPN;
blue).
(B–E) Immunofluorescence labeling of coronal sections of
E15.5 (B), E16.5 (C), E18.5 (D), and P1 (E) mouse
neocortex with antibodies to BCL11B, TLE4, and SATB2
and corresponding FACS plots from dissociated cortex
highlighting the selection process to identify each cell type
of interest.
(F) Dissociated E18.5 cells prior to FACSwith labeled CPN
(arrowheads), ScPN (arrows), and CThPN (open arrow-
heads).
(G) Gene-level RNA-seq expression profiles for Bcl11b,
Satb2, and Tle4 confirm expression in specific cellular
populations. Lines represent Cuffdiff2 expression esti-
mates; shaded areas represent 95% confidence intervals.
(H) A heatmap of row-mean-centered gene-level expres-
sion patterns for known subtype-specific genes confirms
the specific identities of the three isolated neuronal
populations.
Scale bars, 50 mm (B–E) and 20 mm (F). See also Figure S1.
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2013; Lein et al., 2007; Lodato et al., 2014; Molyneaux et al.,
2007; 2009) for which we now provide detailed profiles of tempo-
ral changes in expression. Notably, most genes that distinguish
between ScPN and CThPN are not expressed until E16.5.
To evaluate the purity of the sorted populations, we investi-
gated genes with known expression in interneurons, oligoden-
dryoctes, astrocytes, and endothelial cells (e.g., Dlx1, Gad1,
Gad2, Sox10, Gfap, and Vwf; Figures S1D–S1H) that normally
would not be expressed in these populations. We observed
that they were not expressed in most samples, indicating that
these populations have minimal contamination with other cell
types. The singular exception was the CPN samples from
E15.5, where the FACS plots demonstrated that the SATB2-
high population was not a clearly distinct population for gating
(Figure 1B, CPN gate) and had low, yet detectable, levels of
expression of Dlx1, Gad1, Gad2, Sst, and Lhx6, indicating
possible contamination from migrating interneurons (Figures
S1D and S1E). Intriguingly, we found that the P1 CThPN popula-
tion also expressed somatostatin (Sst), a genewhose expression
is normally associated with subpopulations of interneurons (Ka-
waguchi and Kubota, 1997). However, in contrast to the E15.5
CPN samples, other known markers of interneurons were not
expressed in P1 CThPN at levels strikingly different from other
conditions (e.g., Dlx1, Gad1, Gad2, Slc32a1; Figures S1D and
S1E). This observation indicates that Sst expression might not
be the result of contamination by interneurons, but that this
gene is differentially expressed in CThPN or a subpopulation of
CThPN. Together, these data demonstrate that FACS purifica-
tion with antibodies to cell-type-specific transcription factors
can be utilized to obtain high-quality RNA to resolve transcrip-
tional dynamics.
Identification of Genes Contributing to Class-Specific
Neuronal Identity
We first sought to identify genes with significant differences
in gene-level expression over time or between subtypes and
used these expression estimates to identify clusters of meaning-
ful expression patterns. Cuffdiff2 was used to identify 8,864
genes (8,058 protein-coding and 806 lncRNAs) with significant
(q < 0.0004; Cuffdiff2 test) differential expression between cell
types and developmental stages. Examining all pairwise differ-
ences between conditions, we can describe the set of all genes
that change during both neuronal differentiation over time and
subtype specification during corticogenesis. These 8,864 genes
represent a comprehensive list of PolII transcribed elements
that significantly distinguish these neuronal populations duringFigure 2. Comprehensive Transcriptional Analysis of Neuronal Cell-Ty
(A) Heatmaps of the row-mean-centered expression profiles for the 25 most spe
(B) A 20-way clustering solution of differential gene expression profiles. Cluster
proportion of genes in each cluster that are lncRNAs (red) or protein-coding gen
(C) Density plots of gene expression estimates (FPKM) for lncRNAs (red) and pro
(D) Cumulative density of maximum specificity scores across each condition fo
learned empirical distribution of lncRNA maximum FPKM values (black; 1,000 sa
(E) Distributions of K-S test p values for resampled protein-coding gene max spe
(F) Smoothed spline illustrating the fitted inverse relationship between expressio
gene type.
(G) Significant effects on gene specificity scores attributed to the explanatory v
specificity and expression. See also Figures S2 and S3.cortical development and were utilized in select downstream an-
alyses to investigate the dynamics of gene expression.
To disentangle gene expression changes that correlate with
general neuronal maturation from those that correlate with cell-
type specification, we performed principal component analysis
(PCA) independently on the significant protein-coding genes
and lncRNAs. PCA on the protein-coding genes revealed that
neuronal maturation over embryonic time was a greater source
of variability than neuronal subtype differentiation (Figure S2A).
In contrast, PCA on significant lncRNAs identified principal com-
ponents that were mixed for both temporal and neuronal cell-
type-specific contexts (Figure S2B).
To identify marker genes that appropriately distinguish be-
tween these three neuronal subtypes and might play functional
roles in their development and function, we sought to identify
those genes that exhibit the highest degree of cell-type speci-
ficity. To this end, we ranked all significantly differentially ex-
pressed genes using a custom similarity score based on the
Jensen-Shannon distance between the gene’s normalized
expression and an ideal gene with uniform expression for a given
cell type across time (Experimental Procedures). For each cell
type, the top 25 most specific genes that meet this criteria are
presented in Figure 2A. As anticipated, several genes with previ-
ously described expression in each cell type were identified,
including Lhx2, Cux1, and Cux2 for CPN (Bulchand et al.,
2003; Nieto et al., 2004), Oma1 and 6430573F11Rik for ScPN
(Arlotta et al., 2005), and Tle4 and Ngfr in the corticothalamic/
subplate population (Allen and Lobe, 1999; Allendoerfer et al.,
1990). In addition to previously known markers, we identified
many genes, including lncRNAs, as being specifically expressed
within these three neuronal populations. In situ hybridization for
12 such genes confirmed highly restricted patterns of expression
in the developing cortex consistent with their RNA-seq expres-
sion profiles (Figures S3A–S3L). For example, RNA-seq data
reveal that linc-Cyp7b1-3 is expressed in ScPN, and in situ hy-
bridization demonstrates expression restricted to a subset of
layer V cells, consistent with restriction to ScPN (Figure S3J).
Together, these results suggest that many lncRNAs identified
have consistent expression patterns in vivo.
We sought to obtain an unbiased view of the various expres-
sion profiles used during specification and maturation of these
cell types to begin to discern patterns of coregulation. We
distilled the significant gene expression profiles into 20 distinct
patterns of gene expression using nearest-neighbor agglomera-
tive graph clustering on cosine similarities (Table S3; see Exper-
imental Procedures). The resulting clusters were manuallype Specificity
cific genes for each neuronal subtype.
s are manually grouped by cell-type specificity. Inlaid pie charts indicate the
es (gray). Shaded areas represent 95% confidence intervals.
tein-coding genes (black).
r protein-coding genes (blue), resampled protein-coding genes drawn from a
mples individually plotted at each time point), and lncRNAs (red).
cificity scores versus lncRNA max specificity scores at each time point.
n level (FPKM) and max cell-type specificity score at each time point for each
ariables gene type or time after fitting a generalized additive model between
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partitioned into five distinct groups: three groups of ‘‘class-spe-
cific signature clusters’’ (CPN, ScPN, and CThPN), one group of
‘‘mixed-cell type’’ clusters whose genes demonstrate expres-
sion in only two cell types (i.e., corticofugal, which includes
ScPN and CThPN), and one group of clusters whose genes
demonstrate consistent expression between all cell types, either
increasing or decreasing over time (Figure 2B). Genes within the
subclass-signature clusters represent likely candidates that may
contribute to neuronal cell-type specification or subtype-specific
activities, while those genes in the latter clusters are most likely
associated with broader neuronal differentiation processes
shared among distinct neuronal cell types.
The organization of these data into clusters of similarly regu-
lated genes vastly expands upon the list of known cortical
neuron subtype specific genes. For example, cluster 11 contains
Bcl11b (Ctip2), which plays a key role in mediating ScPN axonal
projections to the spinal cord (Arlotta et al., 2005).Bcl11b shares
a similar expression profile with 218 other genes within cluster 11
demonstrating elevated expression in ScPN from the earliest
stages of development. Cluster 16 contains the known ScPN
genes Crim1, Crym, and Diap3 (Arlotta et al., 2005), as well as
743 other genes with subcerebral-specific profiles that increase
in expression during development. Each of these clusters con-
tains both lncRNAs and protein-coding genes (Figure 2B; pie
chart inlays).
In order to understand the relative contribution of lncRNAs and
protein-coding transcripts to cell-type specificity, we compared
a calculated maximum specificity score (Cabili et al., 2011) for
protein-coding genes and lncRNAs across all three cell types
at each time point. Given the complexity of comparing specific-
ities when lncRNAs as a population are expressed at significantly
lower levels than protein-coding genes (Figure 2C; Cabili et al.,
2011), we examined specificity scores using two different
methods to correct for the confounding influence of expression
level.
First, we resampled protein-coding genes drawn from the
learned empirical distribution of lncRNA maximum FPKM values
for each time point. For each of the 1,000 samples (Figure 2D,
black lines), we performed a Kolmogorov-Smirnov (K-S) test
between the cumulative densities of the lncRNA maximum
specificity scores (Figure 2D, red lines) and the scores for
the resampled protein-coding genes. Next, to more appropri-
ately model cell-type specificity as a continuous function of
expression levels, a generalized additive model (GAM) was fit
across all genes with maximum specificity as the response var-
iable and maximum FPKM expression, cell type, and develop-
mental time as explanatory variables (Figure 2F; Experimental
Procedures).
We observed that expression level accounts for the majority
of variation in cell-type specificity in our data (Figure 2F).
While lncRNAs were slightly more cell type specific than pro-
tein-coding genes (Figures 2D and 2E, by K-S test >97% of
the resampled specificity distributions are different for all time
points, p < 0.01; Figures 2F and 2G, by GAM p < 3.2e-06,
Pr(< jtj)), the magnitude of the difference is small. Interestingly,
we also observed a significant increase (p < 0.00015; Pr(< jtj))
in specificity for both lncRNAs and protein-coding genes
over the course of cortical neuron development (Figure 2G;280 Neuron 85, 275–288, January 21, 2015 ª2015 Elsevier Inc.second panel), consistent with increased transcriptional diver-
gence between neuronal cell types over developmental time.
Together, these data indicate that lncRNAs have a small, sta-
tistically significant increase in specificity after correcting for
expression; this difference is small and its biological value
hard to define.
Transcriptional Dynamics of LncRNAs
Our data provide a context in which to examine the relative con-
tributions of specific lncRNAs to neuronal cell-type identity, as
opposed to previously recognized tissue-level differences. We
decided to examine in more detail the lncRNAs that were iden-
tified in these neurons. We assembled a total of 5,195 lncRNA
genes from our RNA-seq data, 1,136 of which represent unique
gene loci compared to the UCSC mm9 reference transcriptome
(Figure 3A, detailed in Experimental Procedures). In addition,
we identified 2,978 known lncRNA gene loci and 512 unique
isoforms of known lncRNA genes from our data (Figure 3A).
We assembled 500 lncRNAs characterized as antisense to a
known gene. However, we chose to remove these antisense
lncRNAs from our quantification and differential expression as-
says since overlapping protein-coding gene expression would
confound accurate expression estimates from unstranded
libraries.
We observed 806 lncRNAs that exhibit significant (q < 0.0004;
Cuffdiff2) changes in expression over time or between cell types
(Figure 3B). Of the 806 significant lncRNAs, 449 lncRNAs
(55.7%; 135 CPN, 180 ScPN, 134 CThPN) are assigned to cell-
type signature clusters, while 259 lncRNAs (32.1%) are associ-
ated with cell-type independent clusters. The remaining 87
lncRNAs (10.8%) can be found in the mixed cell-type clusters.
The bulk of the significant lncRNAs (688; 85.4%) are intergenic
to known genes, and the remaining 118 (14.6%) share a bidirec-
tional promoter with a known protein-coding gene.
We next assessed the specificity of our discovered lncRNAs
for expression within the brain relative to other tissues. We
quantified the expression of the 806 significant lncRNAs across
a panel of 29 publicly available RNA-seq datasets (detailed
in Experimental Procedures). A total of 49.4% of significant
lncRNAs (398/806) were detected at FPKM > 2 in at least
one of the tissues sampled. As expected, the number of tissues
in which a given significant lncRNA was expressed with an
FPKM > 2 (Figure 3C) was dramatically lower (mean 2.7; median
0) compared to the counts for significant protein-coding genes
(mean 16.3; median 19).
We next asked whether we could identify any significantly
regulated lncRNAs with potential human syntenic equivalents.
Of the 806 significant lncRNAs, 175 (21.7%) have an identifiable
syntenic human equivalent (Table S4), as defined by the
presence of a transcribed element within the same syntenic
region in the human genome (hg19; TransMap; detailed in
Experimental Procedures). This fraction is consistent with previ-
ous observations of the lncRNAs with putative human orthology
(Cabili et al., 2011). Interestingly, despite syntenic transcription,
these particular lncRNAs do not demonstrate any significant
difference in cell-type specificity within our cortical differentia-
tion dataset relative to lncRNAs with no discernable human
ortholog (Figure 3D).
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Figure 3. Cell-Type-Specific LncRNAs in the
Developing Neocortex
(A) Pie chart detailing the distribution of 5,195
lncRNAs identified in the pyramidal neuron tran-
scriptome.
(B) Heatmap of differentially expressed protein-cod-
ing genes and lncRNAs.
(C) The number of tissues with detectable expression
for a given significant lncRNA (FPKM R 2) is signifi-
cantly lower (mean 2.7; median 0) than the number
for significant protein-coding genes (mean 16.28;
median 19).
(D) Cumulative densities of maximum cell-type spec-
ificity scores for lncRNAs with a human syntenic
equivalent (red) and those without (black) suggest that
the presence of a lncRNA across species does not
correlate with a change in cell-type specificity.
(E–G) Barplots of estimated expression levels for
linc-Cyp7b1-3 (E), linc-Phf17-2 (F), and linc-
1700066M21Rik-1 (G), lncRNAs that exhibit a high
degree of cell-type specificity for ScPN, CThPN, and
CPN, respectively.
Error bars represent 95% confidence intervals in
expression estimates.
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Many of the identified lncRNAs could be used as neuron-type-
specific markers for each population. For each neuronal cell
type, we observed several lncRNAs with dynamic and specific
expression. For example, linc-Cyp7b1-3 is a multi-exonic inter-
genic lncRNA expressed from chromosome 3 that displays a
high degree of cell type specificity for ScPN (Figures 3E and
S3J). This lncRNA has a PhyloCSF score of 30372, indicating
a very low probability of being a protein-coding gene. Other
lncRNAs, including linc-Phf17-2 (PhyloCSF score 15093) and
linc-1700066M21Rik-1 (PhyloCSF score 30981), demonstrate
remarkable cell type specificity for either CThPNor CPN, respec-
tively (Figures 3F and 3G). These few examples highlight the di-
versity of a large set of cell-type-specific lncRNAs and suggest
that some lncRNAs could be used to classify neuronal subtypes
during cortical development.
Neuronal Subtype-Specific Use of Gene Pathway
Components
We next analyzed our resource for gene sets or pathways that
are differentially regulated in each cell type. We first conducted
a gene ontology enrichment analysis using the lists of genes
differentially expressed between any two neuron types at P1
(5% false discovery rate [FDR]) and additionally filtered by a
maximum specificity score. Reactome gene sets (C2 reactome;
MSigDB; Subramanian et al., 2005) were tested for enrichment
using a hypergeometric test. The list of significant gene sets
was fairly consistent between the three cell types (not shown),
which is expected given that current annotations only cover
broad processes of cellular development and function. We
noticed, however, that for many of the common gene sets, the
individual genes driving these signatures were differentially ex-
pressed between class and time.
We therefore devised a different approach to identify genes
that share similar curated annotations but are uniquely ex-
pressed in a given cell class. To achieve this, all genes were
rank ordered by their maximum specificity for any of the three
neuronal populations at P1 and filtered for a minimum FPKM
expression level of 2. The ranked list was used as input for a pre-
ranked gene set enrichment analysis (GSEA; Subramanian et al.,
2005) against the collection of Reactome gene sets (Figure 4A;
C2 Reactome v4.0; MSigDB).
We observed several pathways that exhibited significant dif-
ferential usage of genes across individual neuronal classes,
including gene sets containing cell surface receptors, potassium
channels, and various components of the extracellular matrix.
Specifically, the top four most significant Reactome gene sets
involve G protein-coupled receptor (GPCR) signaling molecules
including both receptors and ligands, as well as genes involved
in specific downstream signaling cascades (Figure 4B).
To further explore the specific use of GPCR receptor classes
across our three cell types, we generated gene sets from the
curated lists of seven transmembrane (7TM) receptors from the
IUPHAR database of receptors and ion channels (Sharman
et al., 2013). We identified a cohort of metabotropic glutamate
receptors that are differentially used by cortical neuron sub-
types, includingGrm1 andGrm4 (specific toCThPN),Grm2 (spe-
cific to CPN), Grm3 (specific to corticofugal), and Grm5, Grm7,
and Grm8 with shared expression in both CPN and ScPN. In282 Neuron 85, 275–288, January 21, 2015 ª2015 Elsevier Inc.contrast, expression of the two GABAB receptors Gabbr1 and
Gabbr2 remained consistent across all three cell types. Interest-
ingly, we also observed a significant differential usage of several
other 7TM receptor classes, including specific expression of
several 5-HT (serotonin) receptors among the corticofugal cell
types, and highly specific expression of the adrenoreceptors,
including Adra2c in the CPN, Adrb1 in ScPN, and Adra1b and
Adra2a in CThPN. In addition, we also identified a number of
orphan GPCRs with specific subtype expression, including
Gpr158 (CPN), Opn3 and Gpr176 (ScPN), as well as Gpr3,
Gpr22, and Gpr39 (CThPN).
We identified several other gene sets with a significant
enrichment for cell-type-specific genes, including a set con-
taining axon guidance molecules. Analysis of a manually
curated set of known cell surface ligands and receptors with
demonstrated roles in axonal guidance revealed the different
codes of related molecules expressed by each neuronal sub-
type during circuit formation (Figure 4C). Importantly, this de-
gree of specificity is only observed for a select few gene
sets, while the majority, including many genes involved in basal
metabolic processes, are expressed at common levels (Fig-
ure 4D). These results are consistent with a previous study
that broadly suggested that cell surface proteins greatly
contribute to the diversity of CNS cell types (Doyle et al.,
2008). However, here we provide a high-resolution character-
ization of the expression of distinct subsets of genes within
broader gene sets otherwise shared by closely related cortical
projection neuron subtypes that begins to describe subtle dif-
ferences between these classes and their dynamic changes
during development.
Isoform-Level Resolution of Transcriptional Dynamics
during Corticogenesis
The high resolution and depth of sequencing within our resource
allows us to investigate additional aspects of transcriptional
regulation, such as alternative splicing and alternative promoter
usage during corticogenesis (Figure 5A) (Trapnell et al., 2013).
We identified 812 genes that undergo promoter switching,
1,068 genes that significantly alter their protein-coding
sequence, and 1,181 genes that demonstrate significant shifts
in their relative isoform abundance. Interestingly, 597 of these
genes with an alternative regulatory event demonstrate tran-
script-level regulation without significant change in overall
gene expression (Figure 5B). Of these genes, 371 (31.4% of
isoform switching genes) represented significant alternative
isoform usage, 296 (27.7% of CDS switching genes) demon-
strated a significant change in CDS, and 194 (23.9% of promoter
switching genes) demonstrated alternative promoter usage
during corticogenesis (Table S5).
Several genes provide compelling examples of how interpre-
tations of gene-level significant differences would often exclude
genes that use RNA processing as an alternative form of regu-
lation during cortical development. One example is the antero-
grade motor protein Kif1a, a causal gene of hereditary spastic
paraplegia (Klebe et al., 2012), a degenerative disease that
affects corticospinal motor neurons as well as other ScPN.
We observed comparable levels of increasing Kif1a expression
in each cell type (Figure 5C). However, we found that while two
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Figure 4. GPCR and Cell Surface Molecules Are the Leading Indicators of Neuronal Diversity
(A) Significantly (p < 0.001) enriched and depleted gene sets from a preranked gene set enrichment analysis against the Reactome collection of gene sets.
(B) Dot plots of the 50most specific genes at P1within theGPCR ligand binding Reactome gene set. Diameters of the dots aremapped to expression estimates at
P1 and color mapped to relative cell-type specificity.
(C) Dot plots for specific classes of axon guidance molecules reveal that individual neuronal subclasses use different codes of related molecules to inform axonal
targeting decisions.
(D) Dot plot of genes within the lowest-ranked Reactome gene set for contrast. Genes within this set and other basal metabolic processes show little variation
between cell types.of the alternative isoforms for Kif1a are strongly upregulated
over time, the expression of one isoform that is missing a
cassette exon (uc007cdg.2) drops significantly during develop-
ment. Another example is Lrrtm4, an important regulator of
synaptic development with highly selective expression in the
brain (Siddiqui et al., 2013), which exhibits significant antithet-ical isoform regulation in ScPN and CThPN with one isoform
increasing in ScPN while another is decreasing in CThPN (Fig-
ure 5D). Lastly, Rbm7, a putative RNA binding protein (Lubas
et al., 2011), appears at the gene level to maintain stable
expression in all three cell types over time (Figure 5E). However,
at the isoform level we observe a complete conversion duringNeuron 85, 275–288, January 21, 2015 ª2015 Elsevier Inc. 283
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Figure 5. Regulated Programs of Gene
Expression at the Isoform Level
(A) Schematic depicting the number of genes that
undergo promoter switching, alter their protein-
coding sequence, or demonstrate shifts in isoform
abundance.
(B) Euler diagram describing the total number of
significant regulatory events identified, including
those that take place without detectable changes
in overall gene expression (red oval).
(C) Kif1a gene level expression increases over
time, while individual isoforms undergo a dramatic
shift in expression from isoform uc007cdg.2 to
isoform uc007cdf.2.
(D) Diametrically opposing changes in expression
are observed for two Lrrtm4 transcript variants in
ScPN and CThPN.
(E) Insignificant gene level expression estimates
for Rbm7 belie a significant shift in expression at
the isoform level.
(F) This results in a switch to a significantly trun-
cated peptide as a result of the inclusion of three
in-frame stop codons for the uc009pif.2 isoform.
(G) RT-qPCR confirms that RNA-seq detected
expression dynamics from E15 to P1 between all
isoforms, uc009pie.2 (p = 0.0035), and uc009pif.2
(p = 0.016). *p < 0.05; **p < 0.01. Error bars
are SEM.
Shaded areas in (C)–(E) represent 95% confidence
intervals.cortical development from the expression of isoform uc009-
pie.2, which codes for a 265 amino acid protein, to isoform
uc009pif.2, which includes an alternatively spliced exon with
three in-frame stop codons that results in a truncated peptide
(Figure 5F). Rbm7 isoform level differences identified by RNA-
seq were confirmed by quantitative RT-PCR (Figure 5G). These
examples of isoform level changes in expression demonstrate
the importance of examining the dynamics of the transcriptome
at the subgene level to identify significant differences between284 Neuron 85, 275–288, January 21, 2015 ª2015 Elsevier Inc.the use of individual isoform, promoter,
and transcription start sites by different
neurons.
DeCoN: The Developing Cortical
Neuron Subtype Transcriptome
Resource
As part of this study, we have created
an interactive companion website to
facilitate future analysis and exploration
of these data (http://decon.fas.harvard.
edu). This website will enable investiga-
tors to visualize, query, and manipulate
the extensive transcriptome data pre-
sented here and serve as a repository
for future transcriptomic and epigenetic
data on cell-type-specific development
in the neocortex. At both the gene and
gene set level, we have provided several
web-based visualization tools to investi-gate this dataset using all of the analyses described here as
well as additional exploratory tools, including utilities for gene
discovery.
When possible, these data are integrated with existing data
from various external sources, including Allen Brain Atlas
in situ hybridization data (Lein et al., 2007) and processed
RNA-seq reads via tracks in the UCSC Genome Browser, to
facilitate a thorough exploration of the data (Raney et al.,
2014). The experimental methodology, rich data resource, and
user-friendly interface for analysis at the gene and system levels
provide a critical platform for understanding the genome-wide
transcriptional dynamics of neuronal differentiation.
DISCUSSION
To begin to characterize the transcriptional events responsible
for the establishment of the neuronal diversity of the neocortex
in greater detail, we developed a high-throughput experimental
method, combined with massively parallel RNA sequencing,
and robust systems-level analyses to characterize the transcrip-
tional dynamics of three neuronal populations during develop-
ment. We built an interactive platform (DeCoN: The Developing
Cortical Neuron Transcriptome Resource) to enable multidimen-
sional data mining, exploration, and dissemination that is scal-
able and designed to integrate future data on additional neuronal
classes and different species.
High-Throughput Isolation of Neuronal Subtypes
A key feature of the CNS is the incredible diversity of cell types.
Antibody-based discrimination of distinct cell types has enabled
high-throughput study in the immune and hematopoietic sys-
tems. Similar methods are lacking for parsing the heterogeneity
of the CNS, and the field has lagged considerably behind efforts
in other tissues due to the fragility of neurons and the fact
that many cell-type-specific neuronal cell surface markers are
localized to the axon or dendrites rather than on the soma and
thus are lost during tissue dissociation. Here, using fixed neu-
rons, we demonstrate that FACS purification with antibodies to
cell-type-specific transcription factors can be utilized to finely
discriminate between different populations of neuronal sub-
types, despite dynamic profiles of transcription factor expres-
sion during development.
It is increasingly evident that cortical projection neuron sub-
types are themselves heterogeneous (Hoerder-Suabedissen
and Molna´r, 2013; Sorensen et al., 2013). The true diversity of
neocortical neurons is yet to be determined but can be more
readily explored with antibodies to additional transcription fac-
tors or intracellular epitopes to further subdivide and refine the
molecular taxonomy of the populations described here.
Because these methods do not require genetic labeling, this
approach opens the door for investigations of specific neuronal
populations in the human and nonhuman primate brain, which
has thus far been limited to laser capture microdissection of
individual cells or broad regions (Hawrylycz et al., 2012; Johnson
et al., 2009; Kang et al., 2011; Oldham et al., 2008). Adopting this
approach will greatly facilitate the study of disease susceptibility
of selected classes of neurons in humans (Saxena and Caroni,
2011).
Notably, since neurons are fixedprior to FACSpurification, they
readily withstand higher-pressure FACS conditions, which have
traditionally limited the ability to purify large numbers of neurons.
This advantage makes possible the collection of millions of neu-
rons of a particular subtype, enabling broad, multidimensional
profiling of the transcriptome and epigenome in mouse and
human models of development and disease. Additionally, with
markers identified here, it will be possible to further subdivide in-
dividual classes to explore pyramidal neuron heterogeneity.Insights into the Transcriptional Complexity of Closely
Related Neuronal Subtypes
The process of neuronal specification, migration, and circuit for-
mation is complex, with multiple levels of regulation. Through
deepsequencingofdevelopingpyramidal neuron transcriptomes,
we can describe the extent of transcriptome changes, including
isoform-level transcriptional regulation as well as the differential
use of multiple promoters and transcription start sites (TSS) as
means to add variety and diversity to the transcriptional output.
The accurate and complete assembly of lncRNA transcripts
remains a difficult problem generally complicated by the lower
relative abundance and lagging curation and annotation of
full-length lncRNA transcripts. The combination of cell-type pu-
rity and deep sequencing in our data enhances the likelihood
that our assembled lncRNAs represent full-length transcript re-
constructions, since read coverage is the strongest predictor
of assembly quality (Steijger et al., 2013). We have attempted
to minimize the impact of low read coverage on the quality of
our assembled lncRNAs by requiring that any lncRNA transcript
have a minimum of 3.03 coverage, a threshold previously deter-
mined to provide an estimated >80% recovery rate of well-anno-
tated protein-coding exons using Cufflinks (Steijger et al., 2013).
It must be noted, however, that experimental validation of indi-
vidual lncRNA transcripts currently remains the gold standard
for assessing assembly quality. Additional attempts to minimize
the error rates for our assembly involved the selection of a
PhyloCSF score threshold of 100, which was previously demon-
strated to correspond to a false negative error rate of 6% for
protein-coding genes and a false positive error rate of 9.5%
(Cabili et al., 2011). Most stringently, we also exclude transcripts
with any significant Pfam hit in any of the three possible reading
frames. The result is a catalog of assembled lncRNA transcripts
from discrete neuronal populations that benefits from the
increased depth of sequencing and the relative cellular homoge-
neity of the input materials.
Using this lncRNA catalog, we find that these genes are at
least as specific as protein-coding genes of comparable expres-
sion levels in distinguishing individual pyramidal neuron sub-
types. The data also highlight the importance of accounting for
differences in level of expression when comparing the specificity
of lncRNAs and protein-coding genes.
Though only a handful of lncRNAs have been functionally
examined, increasing evidence suggests that lncRNAs have
diverse biological functions, including chromatin modification,
transcriptional regulation, and posttranscriptional processing
(Mercer et al., 2009). LncRNAs also appear to play roles in the
specification and maintenance of cell identity (Guttman et al.,
2011; Sauvageau et al., 2013; Sun et al., 2013). Global transcrip-
tome studies of whole-brain or microdissected layers have
identified numerous lncRNAs expressed in the cortex (Ayoub
et al., 2011; Belgard et al., 2011; Mercer et al., 2008; Ponjavic
et al., 2009; Zhang et al., 2014). The current data suggest that
lncRNAs might contribute to subtype-specific neuronal proper-
ties and provide a more comprehensive list of marker genes
and potential therapeutic targets. Although functional analysis
of lncRNAs is in its infancy and inherently challenging (Bassett
et al., 2014), here we provide hundreds of subtype-specific
lncRNAs as candidates to investigate the contributions ofNeuron 85, 275–288, January 21, 2015 ª2015 Elsevier Inc. 285
lncRNAs to the development and function of distinct neuronal
populations.
Scalable Platforms for Data Analysis
A comprehensive description of the transcriptional programs
controlling neuronal specification represents a large dataset
that requires new interactive tools to permit full exploration of
the data by investigators. Here, we have established an interac-
tive web platform that allows users to easily examine gene and
isoform level expression data, explore clusters of related genes,
discover new genes with user-defined expression profiles, and
links to displays of processed RNA-seq reads on the UCSC
Genome Browser. Continually expanding databases of in situ
hybridization and tissue level transcriptome data, such as the
Allen Brain Atlas (Lein et al., 2007) and the UCSC Genome
Browser (Raney et al., 2014), are integrated into this dataset to
facilitate more integrative analyses of these data.
The resolution of RNA-seq highlights the extensive regulation
at the isoform level for individual neuronal subtypes, and these
data are now available for investigators to examine for individual
genes or gene sets of interest. Beyond the expression of iso-
forms, our data provide the means to identify novel transcript
variants not described here that can be assembled from this
resource. Future expansion of this resource with additional tran-
scriptomic and epigenetic data from these and other populations
of cortical neurons will enable a more comprehensive under-
standing of the molecular programs driving corticogenesis.
EXPERIMENTAL PROCEDURES
FACS Purification
All animals were handled according to protocols approved by the Institutional
Animal Care and Use Committee (IACUC) of Harvard University. For each bio-
logical replicate, the somatosensory cortex of one litter of CD1 embryos or
pups (6–10 per litter) was dissociated into single-cell suspension as previously
described (Arlotta et al., 2005), and cells were fixed immediately with 4% para-
formaldehyde. The protocol for intracellular staining and RNA isolation was
modified from Hrvatin et al. (2014). Single-cell suspension of fixed cells was
immunostained under RNase free conditions with anti-SATB2, anti-CTIP2,
and anti-TLE4. Appropriate gates for FACS were set based on relative levels
of SATB2, CTIP2, and TLE4 expression to isolate CPN, ScPN, and CThPN
as described in Figure 1. Additional information is in the Supplemental Exper-
imental Procedures.
Immunohistochemistry and In Situ Hybridization
Immunohistochemistry and in situ hybridization were performed as previously
described (Lodato et al., 2014; Molyneaux et al., 2005). In situ probes are
detailed in Table S6. Additional information is in the Supplemental Experi-
mental Procedures.
RNA Isolation
RNA was recovered from FACS-purified cells using the RecoverAll Total Nu-
cleic Acid Isolation Kit (Ambion) according to manufacturer’s instructions,
except proteinase K digestion was performed at 50C for 3 hr. RNA concentra-
tion was quantified with Nanodrop 1000, and quality was determined with an
Agilent 2100 Bioanalyzer. RNA integrity numbers (RINs) for all samples were
between 6.3 and 9. Typical yieldwas between 1 and2pgRNAper sorted event,
requiring approximately 100,000 cells to yield 200 ng RNA for library input.
RNA-Seq, Transcriptome Assembly, and Differential Expression
Purified RNA served as input for the standard Illumina RNA-seq library prepa-
ration with poly(A) selection. A total of 100 base pair paired end reads were286 Neuron 85, 275–288, January 21, 2015 ª2015 Elsevier Inc.mapped to the mouse genome (mm9) using Tophat2 (Kim et al., 2013) with
an average of 1.09 3 108 mapped reads (range = 7.62 3 107–1.33 3 108;
SD = 1.30 3 107) and assembled into transcripts using Cufflinks (Trapnell
et al., 2010). Individual assemblies were merged using Cuffmerge and UCSC
coding genes as a reference. The merged assembly was used as input for
our previously described lncRNA identification pipeline (Cabili et al., 2011).
Assembled lncRNAswere appended to the list of known UCSC protein-coding
genes to establish a suitable reference transcriptome. Differential expression
testing was performed between all pairs of conditions using Cuffdiff2. Data
were visualized using the cummeRbund package from Bioconductor (Gentle-
man et al., 2004; Trapnell et al., 2012) and additionally integrated into the De-
CoN interactive web resource. Additional information is in the Supplemental
Experimental Procedures.
PCA and Cluster Analysis
Principal component analysis was performed on individual gene-level frag-
ments per kilobase of RNA per million reads mapped (FPKM) using the
cummeRbund package in R on the lists of significant protein-coding and
lncRNA genes. A 20-way clustering solution of differential gene expression
profiles was obtained using nearest-neighbor agglomerative graph clustering
on cosine similarities using the CLUTO utility (described in Zhao and Karypis,
2005). Additional information is in the Supplemental Experimental Procedures.
LncRNA and Protein-Coding Gene Specificity Analysis
Maximum specificity scores were calculated for protein-coding genes and
lncRNAs across all three cell types at each time point as described in Cabili
et al. (2011). To correct for the confounding influence of expression level, we
(1) compared lncRNA specificity scores to resampled protein-coding genes
drawn from the learned empirical distribution of lncRNA maximum FPKM
values for each time point and (2) employed a generalized additive model
(GAM) using the (mgcv) R package (Wood, 2011) to appropriately model the
observed nonlinear relationship between expression level (FPKM) and speci-
ficity (S), and to identify any significant effects of gene biotype on specificity,
and the observed increase in specificity at each time point. Additional informa-
tion is in the Supplemental Experimental Procedures.
Identification of Syntenic Positional Equivalents
LncRNA human syntenic positional equivalents were defined by the presence
of a transcribed element, within the same syntenic region in the human
genome (hg19; TransMap). Additional information is in the Supplemental
Experimental Procedures.
Quantitative RT-PCR
Real-time PCR was performed using TaqMan Gene Expression Assays
(Applied Biosystems) according to the manufacturer’s protocol for standard
cycling conditions. Additional information is in the Supplemental Experimental
Procedures.
ACCESSION NUMBERS
The NCBI Gene Expression Omnibus accession number for the RNA-seq data
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